Cite Filings / KPTI / 9999999995-24-001788
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
EFFECT

Notice of Effectiveness

Karyopharm Therapeutics Inc. · Filed 2024-06-07 · Acc 9999999995-24-001788

Documents 1

  • EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

  • 2026-05-14 EFFECT Notice of Effectiveness
  • 2024-06-07 EFFECT Notice of Effectiveness
  • 2024-06-07 4 Director sold 818,044 shares at an average $0.96 ($785,027)
  • 2024-06-06 4 EVP, CFO & Treasurer sold 652 shares at $0.99 ($645)
  • 2024-06-06 4 President and CEO sold 3,592 shares at $0.99 ($3,556)
  • 2024-06-05 CORRESP Correspondence Between Filers and SEC Staff
  • 2023-05-05 EFFECT Notice of Effectiveness

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…